Exogenous nitric oxide increases basal leg glucose uptake in humans

Metabolism. 2003 Jun;52(6):662-5. doi: 10.1016/s0026-0495(03)00062-3.

Abstract

This study addressed the role of blood flow and nitric oxide in leg glucose uptake. Seven subjects (5 men, 2 women) were studied during conditions of resting blood flow and increased blood flow, achieved by infusion of the nitric oxide (NO) donor sodium nitroprusside (SNP) into the femoral artery. Femoral arterial and venous blood samples were obtained and blood flow was determined by infusion of indocyanine green dye. SNP infusion significantly increased leg blood flow (769 +/- 103 v 450 +/- 65 mL. min(-1). leg(-1), P <.001), but did not affect arterial (4.68 +/- 0.13 mmol/L control, 4.63 +/- 0.09 mmol/L SNP) or venous (4.60 +/- 0.14 mmol/L control, 4.54 +/- 0.10 mmol/L SNP) glucose concentrations. Glucose uptake was significantly (P <.01) higher during SNP infusion (65 +/- 6 micromol. min(-1). leg(-1)) than during the basal period (34 +/- 6 micromol. min(-1). leg(-1)), whereas lactate release was unaffected (rest, 45 +/- 11 micromol. min(-1). leg(-1); SNP, 42 +/- 14 micromol. min(-1). leg(-1)). We conclude that blood flow and/or NO increase basal leg glucose uptake.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Coloring Agents
  • Female
  • Femoral Artery / drug effects
  • Femoral Artery / physiology
  • Femoral Vein / physiology
  • Glucose / metabolism*
  • Humans
  • Indocyanine Green
  • Injections, Intra-Arterial
  • Leg*
  • Male
  • Nitric Oxide / pharmacology*
  • Nitric Oxide Donors / administration & dosage
  • Nitric Oxide Donors / pharmacology
  • Nitroprusside / administration & dosage
  • Nitroprusside / pharmacology
  • Regional Blood Flow / drug effects
  • Vasodilator Agents / pharmacology*

Substances

  • Coloring Agents
  • Nitric Oxide Donors
  • Vasodilator Agents
  • Nitroprusside
  • Nitric Oxide
  • Indocyanine Green
  • Glucose